Validation of HER2 Status in Whole Genome Sequencing Data of Breast Cancers with the Ploidy-Corrected Copy Number Approach

BACKGROUND AND OBJECTIVE: Human epidermal growth factor receptor 2 (HER2) protein overexpression is one of the most significant biomarkers for breast cancer diagnostics, treatment prediction, and prognostics. The high accessibility of HER2 inhibitors in routine clinical practice directly translates...

Descripción completa

Detalles Bibliográficos
Autores principales: Wojtaszewska, Marzena, Stępień, Rafał, Woźna, Alicja, Piernik, Maciej, Sztromwasser, Pawel, Dąbrowski, Maciej, Gniot, Michał, Szymański, Sławomir, Socha, Maciej, Kasprzak, Piotr, Matkowski, Rafał, Zawadzki, Paweł
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766398/
https://www.ncbi.nlm.nih.gov/pubmed/34932189
http://dx.doi.org/10.1007/s40291-021-00571-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766398/
https://www.ncbi.nlm.nih.gov/pubmed/34932189
http://dx.doi.org/10.1007/s40291-021-00571-1

Ejemplares similares